Related Experiment Video
Updated: Oct 9, 2026

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
Published on: January 25, 2016
Different clinical characteristics of aminoglycoside-induced profound deafness with and without the 1555 A-->G
T Tono1, K Kiyomizu, K Matsuda
1Department of Otorhinolaryngology, Miyazaki Medical College, Miyazaki, Japan. tono@post1.miyazaki-med.ac.jp
Abstract:
Recent genetic studies have shown that hereditary susceptibility to aminoglycoside antibiotics is caused by the 1555 A-->G mitochondrial mutation. We found the 1555 mutation in 4 out of 68 postlingual deaf patients who were candidates for cochlear implantation. All 4 patients developed bilateral profound hearing loss following administration of aminoglycosides. The pedigree of the family shows exclusively maternal transmission of hearing impairment in each case. On comparison with neuro-otological findings from aminoglycoside-induced deaf patients without the 1555 mutation, four distinct characteristics were noted: (1) a progressive nature of hearing loss; (2) better residual pure-tone thresholds; (3) lower thresholds for electrical promontory stimulation, and (4) well-preserved vestibular function. Although other factors such as differing dosages and/or administration routes may also be involved, profound hearing loss associated with the 1555 mutation may be due to a different pathogenic mechanism, i.e., strial dysfunction rather than a direct insult to the hair cells.
Insights
The 1555 A-->G mitochondrial mutation causes hereditary hearing loss from aminoglycoside antibiotics. This mutation was found in 4 deaf patients, showing maternal transmission and distinct hearing loss characteristics.
Area of Science:
- Genetics
- Otolaryngology
- Mitochondrial Medicine
Background:
- Hereditary susceptibility to aminoglycoside antibiotics is linked to the 1555 A-->G mitochondrial mutation.
- Aminoglycosides can cause profound, irreversible hearing loss.
Purpose of the Study:
- To investigate the prevalence of the 1555 A-->G mitochondrial mutation in postlingual deaf patients undergoing cochlear implantation.
- To characterize the neuro-otological findings in patients with the 1555 mutation compared to those without.
Main Methods:
- Genetic screening for the 1555 A-->G mitochondrial mutation in 68 postlingual deaf patients.
- Analysis of patient pedigrees for maternal transmission patterns.
- Comparison of neuro-otological findings, including hearing loss progression, pure-tone thresholds, electrical promontory stimulation, and vestibular function.
Main Results:
- The 1555 mutation was identified in 4 out of 68 patients, all of whom experienced bilateral profound hearing loss after aminoglycoside exposure.
- Maternal transmission of hearing impairment was observed in all affected families.
- Patients with the 1555 mutation exhibited progressive hearing loss, better residual pure-tone thresholds, lower electrical promontory stimulation thresholds, and preserved vestibular function compared to non-mutation carriers.
Conclusions:
- The 1555 A-->G mitochondrial mutation is a significant genetic factor in aminoglycoside-induced hearing loss.
- The distinct clinical presentation suggests a different pathogenic mechanism, potentially involving strial dysfunction rather than direct hair cell damage.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
ATP Synthase: Mechanism

